ArriVent BioPharma (AVBP) Common Equity (2023 - 2026)
ArriVent BioPharma's Common Equity was $366.84 million in Q2 2026, up 46.8% from $249.87 million a year earlier and up 13.2% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Common Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at ArriVent BioPharma came in at $307.22 million, up 19.2% from FY2024.
- In earlier years, Common Equity was $257.65 million in FY2024 and -$153.19 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q1 2023.
- Compared with a year earlier, Common Equity has increased for four straight quarters, with growth averaging 14.0% over the last six quarters.
- Per Business Quant data, AVBP's Common Equity in the three quarters before Q2 2026 was $323.98 million (Q1 2026), $307.22 million (Q4 2025) and $305 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | 366.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 366.84 Mn |
| Mar 31, 2026 | 323.98 Mn |
| Dec 31, 2025 | 307.22 Mn |
| Sep 30, 2025 | 305.00 Mn |
| Jun 30, 2025 | 249.87 Mn |
| Mar 31, 2025 | 202.54 Mn |
| Dec 31, 2024 | 257.65 Mn |
| Sep 30, 2024 | 277.49 Mn |
| Jun 30, 2024 | 296.66 Mn |
| Mar 31, 2024 | 317.72 Mn |
| Dec 31, 2023 | -153.19 Mn |
| Sep 30, 2023 | -132.60 Mn |
| Jun 30, 2023 | -118.46 Mn |
| Mar 31, 2023 | -97.09 Mn |
API Access
ArriVent BioPharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();